Harvest Fund Management Co. Ltd bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 128 shares of the medical equipment provider’s stock, valued at approximately $120,000.
Several other institutional investors have also recently added to or reduced their stakes in the company. BlackRock Inc. lifted its holdings in shares of Intuitive Surgical by 2,770.9% in the 1st quarter. BlackRock Inc. now owns 2,846,621 shares of the medical equipment provider’s stock worth $2,181,851,000 after acquiring an additional 2,747,465 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Intuitive Surgical by 1.2% in the 1st quarter. Vanguard Group Inc. now owns 2,503,817 shares of the medical equipment provider’s stock worth $1,919,101,000 after acquiring an additional 30,306 shares during the last quarter. FMR LLC lifted its holdings in shares of Intuitive Surgical by 3.4% in the 1st quarter. FMR LLC now owns 2,277,567 shares of the medical equipment provider’s stock worth $1,745,686,000 after acquiring an additional 75,894 shares during the last quarter. Edgewood Management LLC lifted its holdings in shares of Intuitive Surgical by 38.8% in the 1st quarter. Edgewood Management LLC now owns 919,617 shares of the medical equipment provider’s stock worth $704,859,000 after acquiring an additional 257,165 shares during the last quarter. Finally, Alliancebernstein L.P. lifted its holdings in shares of Intuitive Surgical by 3.3% in the 2nd quarter. Alliancebernstein L.P. now owns 690,780 shares of the medical equipment provider’s stock worth $646,135,000 after acquiring an additional 21,795 shares during the last quarter. Hedge funds and other institutional investors own 94.23% of the company’s stock.
Several equities research analysts have recently issued reports on ISRG shares. Morgan Stanley set a $316.67 target price on shares of Intuitive Surgical and gave the stock an “overweight” rating in a report on Monday, May 22nd. Wells Fargo & Company restated an “outperform” rating and issued a $350.00 target price (up previously from $333.33) on shares of Intuitive Surgical in a report on Wednesday, July 12th. Citigroup Inc. restated a “buy” rating and issued a $359.33 target price (up previously from $305.67) on shares of Intuitive Surgical in a report on Monday, July 24th. Cantor Fitzgerald initiated coverage on shares of Intuitive Surgical in a report on Thursday, June 29th. They set a “neutral” rating and a $333.33 price objective for the company. Finally, Zacks Investment Research lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, May 30th. Five investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company’s stock. Intuitive Surgical presently has a consensus rating of “Buy” and an average price target of $366.12.
In other news, SVP Curet Myriam sold 1,202 shares of the stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $950.20, for a total transaction of $1,142,140.40. Following the sale, the senior vice president now owns 1,428 shares of the company’s stock, valued at $1,356,885.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Gary S. Guthart sold 17,975 shares of the stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $937.27, for a total transaction of $16,847,428.25. Following the sale, the chief executive officer now directly owns 101,798 shares in the company, valued at approximately $95,412,211.46. The disclosure for this sale can be found here. Insiders have sold 23,172 shares of company stock worth $21,923,487 in the last three months. Corporate insiders own 2.20% of the company’s stock.
Intuitive Surgical, Inc. (ISRG) traded up 0.27% during midday trading on Monday, hitting $1040.87. 29,503 shares of the stock traded hands. The firm has a market cap of $38.67 billion, a P/E ratio of 49.85 and a beta of 0.38. Intuitive Surgical, Inc. has a 12-month low of $610.71 and a 12-month high of $1,054.77. The company’s 50-day moving average is $984.34 and its 200 day moving average is $884.74. Intuitive Surgical shares are set to split on the morning of Friday, October 6th. The 3-1 split was announced on Friday, August 11th. The newly minted shares will be distributed to shareholders after the closing bell on Thursday, October 5th.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, July 20th. The medical equipment provider reported $1.98 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.93 by $0.05. The business had revenue of $756.20 million for the quarter, compared to analysts’ expectations of $724.51 million. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The business’s quarterly revenue was up 12.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.87 earnings per share. On average, analysts anticipate that Intuitive Surgical, Inc. will post $23.92 EPS for the current fiscal year.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.